Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker GYRE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 3,000 | $6.35 | $19.1K Sale | Form 4 ↗ |
| Jun 11, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 2,800 | $6.17 | $17.3K Sale | Form 4 ↗ |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 5,000 | $6.24 | $31.2K Sale | Form 4 ↗ |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 6,418 | $6.21 | $39.9K Sale | Form 4 ↗ |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 3,000 | $6.15 | $18.4K Sale | Form 4 ↗ |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 14,500 | $6.14 | $89.0K Sale | Form 4 ↗ |
| Jun 5, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 15,401 | $6.40 | $98.6K Sale | Form 4 ↗ |
| Jun 4, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 19,575 | $6.13 | $120.0K Sale | Form 4 ↗ |
| May 26, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 4,000 | $6.10 | $24.4K Sale | Form 4 ↗ |
| May 22, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 3,500 | $6.08 | $21.3K Sale | Form 4 ↗ |
| May 21, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 12,820 | $6.15 | $78.8K Sale | Form 4 ↗ |
| May 20, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 9,400 | $6.15 | $57.8K Sale | Form 4 ↗ |
| May 19, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 9,120 | $6.37 | $58.1K Sale | Form 4 ↗ |
| May 18, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 200 | $6.62 | $1,324 Sale | Form 4 ↗ |
| May 15, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 13,100 | $6.65 | $87.1K Sale | Form 4 ↗ |
| May 14, 2026 | Weiguo Ye Chief Operating Officer | GYRE Gyre Therapeutics, Inc. | Sale | 15,580 | $6.91 | $107.7K Sale | Form 4 ↗ |
| May 6, 2026 | Ying Luo Chief Executive Officer, Director | GYRE Gyre Therapeutics, Inc. | Sale | 10,136 | $8.04 | $81.5K Sale | Form 4 ↗ |
| May 5, 2026 | Ying Luo Chief Executive Officer, Director | GYRE Gyre Therapeutics, Inc. | Sale | 179 | $8.01 | $1,434 Sale | Form 4 ↗ |
| May 28, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 558 | $10.07 | $5,619 Sale | Form 4 ↗ |
| May 27, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.28 | $20.6K Sale | Form 4 ↗ |
| May 23, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 182 | $10.24 | $1,864 Sale | Form 4 ↗ |
| May 22, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.97 | $21.9K Sale | Form 4 ↗ |
| May 21, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.83 | $21.7K Sale | Form 4 ↗ |
| May 20, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.25 | $22.5K Sale | Form 4 ↗ |
| May 19, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.11 | $22.2K Sale | Form 4 ↗ |
| May 16, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.31 | $22.6K Sale | Form 4 ↗ |
| May 15, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.68 | $21.4K Sale | Form 4 ↗ |
| May 14, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 20 | $11.30 | $226 Sale | Form 4 ↗ |
| May 13, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.37 | $22.7K Sale | Form 4 ↗ |
| May 12, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.56 | $21.1K Sale | Form 4 ↗ |
| Mar 21, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 174 | $10.00 | $1,740 Sale | Form 4 ↗ |
| Mar 20, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.09 | $20.2K Sale | Form 4 ↗ |
| Mar 19, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.13 | $20.3K Sale | Form 4 ↗ |
| Mar 18, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 242 | $10.24 | $2,478 Sale | Form 4 ↗ |
| Mar 17, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $12.09 | $24.2K Sale | Form 4 ↗ |
| Mar 14, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $12.31 | $24.6K Sale | Form 4 ↗ |
| Mar 13, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.80 | $23.6K Sale | Form 4 ↗ |
| Mar 12, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.74 | $23.5K Sale | Form 4 ↗ |
| Mar 11, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.40 | $22.8K Sale | Form 4 ↗ |
| Mar 10, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.14 | $20.3K Sale | Form 4 ↗ |
| Mar 7, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 1,906 | $10.13 | $19.3K Sale | Form 4 ↗ |
| Mar 7, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 41 | $12.14 | $498 Sale | Form 4 ↗ |
| Mar 7, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 53 | $13.03 | $691 Sale | Form 4 ↗ |
| Mar 6, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.80 | $21.6K Sale | Form 4 ↗ |
| Mar 5, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.98 | $22.0K Sale | Form 4 ↗ |
| Mar 4, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $10.86 | $21.7K Sale | Form 4 ↗ |
| Mar 3, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.23 | $22.5K Sale | Form 4 ↗ |
| Feb 28, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.41 | $22.8K Sale | Form 4 ↗ |
| Feb 27, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.33 | $22.7K Sale | Form 4 ↗ |
| Feb 26, 2025 | Songjiang Ma President, Director | GYRE Gyre Therapeutics, Inc. | Sale | 2,000 | $11.63 | $23.3K Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances